Floatz logo

Oxycodone

Constipation

Mundipharma Research GmbH & Co KGSmall moleculePhase 3Dormant
BB
67/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
53/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Constipation cohort.

Asset / SponsorPhaseRating
Moa-728
Bausch Health Americas, Inc.
Phase 2BB
N-Methylnaltrexone Bromide
Bausch Health Americas, Inc.
Phase 3BB
Lubiprostone
University of Rochester
Phase 4BB
17-ALLYL-4,5A-EPOXY-3,14-DIHYDROXYMORPHINAN-6-ONE
Mundipharma Research GmbH & Co KG
Phase 3BB
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
University of Illinois College of Medicine at Peoria
Phase 4BB

View all 28 →

Same molecule, other indications

Oxycodone is also rated in:

Low Back PainDormant
BBB
Indicative ·
77 / 100
View asset →
PainDormant
BBB
Indicative ·
74 / 100
View asset →
osteoarthritisDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →